Hemochron Signature Elite is a portable whole blood haemostasis monitoring system, designed for point-of-care testing. From the cardiovascular operating room (CVOR) to the cardiac catheterisation laboratory, haemostasis monitoring depends on fast, accurate and reproducible results — and this system delivers them through easy-to-use, easy-to-transport cartridge-based technology.
For critical patient management decisions, the system performs the activated clotting time (ACT+), the low-range activated clotting time (ACT-LR), the prothrombin time (PT/INR) and the activated partial thromboplastin time (APTT), directly at the patient’s bedside. A single system, with a broad test menu, standardises haemostasis testing across multiple clinical departments, maximising efficiency and compliance.
Hemochron Signature Elite produces an ACT result in less time than traditional systems, through real-time measurement — which can speed up the initiation of the procedure. ACT+ testing allows a faster baseline result, beneficial for anticoagulated patients moving from the catheterisation laboratory to the CVOR.
The optical-mechanical method detects the true clot formation end-point, covering both primary and secondary haemostasis. The ACT+ and ACT-LR tests provide a “maximally activated” clotting time, which: supports current clinical practice guidelines, is less affected by hypothermia and artefacts, shortens the testing time and eliminates variability induced by haemodilution.
| Cartridge | Clinical use | Sample | Measurement range |
|---|---|---|---|
| ACT+ | Moderate–high heparin (1–6 U/mL); cardiac surgery / CPB | Whole blood | 68–1005 sec |
| ACT-LR | Low–moderate heparin (up to 2.5 U/mL); cardiac catheterisation, ECLS | Whole blood | 65–400 sec |
| PT/INR | Monitoring of vitamin K antagonists (e.g. warfarin) | Whole blood (venous or capillary) | 0.8–10 INR |
| Citrate PT | PT on citrated samples, testable up to 2 hours after collection | Citrated whole blood | 0.8–10 INR |
| APTT | Monitoring of low-dose heparin (up to 1.5 U/mL) | Whole blood | 50–345 WBS |
| Citrate APTT | APTT on citrated samples, testable up to 1 hour after collection | Citrated whole blood | 50–345 WBS |
PT/INR and APTT testing does not require sample preparation or centrifugation, and the analysis takes under 2 minutes — ideal for the fast flow of the Emergency Department.
The system is used in a wide range of contexts: the operating room, the cardiac catheterisation laboratory, the Emergency Department (ED), the “stat” laboratory, radiology, interventional neuroradiology, Intensive Care (ICU), the electrophysiology laboratory and the anticoagulation clinic.
| Technology | Optical-mechanical, with clot end-point detection |
|---|---|
| Dimensions (L × W × H) | 19 × 9.4 × 5 cm |
| Weight | 0.53 kg |
| Test precision | ≤10% CV for whole blood samples |
| Sample type | Fresh or citrated whole blood |
| Sample volume used | ~15 µL (1–2 drop fill, 35–50 µL) |
| Data storage | Up to 600 patient samples and QC results |
| Battery | Rechargeable lithium-ion |
| Operating environment | 15–30 °C, 20–85% RH (non-condensing) |
| EQC | 2 levels of internal electronic control, automatic or manual |
| Calibration | Factory calibrated; requires no additional calibration by the user |
Interested in this equipment?
Contact us →